Biomea Fusion Inc (BMEA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.45
• Market Cap: $99.69M
• EPS: $-2.25
• 52-Week High: $3.08
• 52-Week Low: $0.87

Market Sentiment

Biomea Fusion Inc currently has a Neutral sentiment score of 0.11.

About Biomea Fusion Inc

Biomea Fusion Inc. is an innovative biopharmaceutical company headquartered in Redwood City, California, focused on developing cutting-edge irreversible small molecules for the treatment of genetically defined cancers. By harnessing advanced scientific methodologies, Biomea aims to meet the significant unmet medical needs of patients with specific genetic mutations, thereby establishing itself as a leader in the field of targeted cancer therapies. With a robust clinical pipeline and a strateg...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biomea Fusion Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BMEA pay dividends?

Biomea Fusion Inc (BMEA) does not currently pay a regular dividend.

What is BMEA's market cap?

Biomea Fusion Inc (BMEA) has a market capitalization of $99.69M with a current stock price of $1.45.